The ALSSA Board of Directors recently decided to extend ALSSA's reach to include diagnostics and to increase the attention given to diagnostics technologies and markets in our meetings and programs. The Board also decided to recruit diagnostic/molecular diagnostic companies to our membership.
Our specific focus will be on molecular diagnostics (the use of DNA, RNA and proteins to test for specific states of health or disease) including companion diagnostics and emerging/next generation in vitro diagnostic technologies such as cellular diagnostics, and to companies developing products in those areas. Our attention will not extend to the mature clinical and immuno in vitro diagnostics markets.
For further information regarding our diagnostics initiative, click on the following links:
"ALSSA is the single most important organization that I belong to because it keeps me in touch with everyone that matters in our industry."
Tim Harkness
President & CEO
ProteinSimple